Back to search

Collection of Transplant Stem Cells for Plasma Cell Myeloma

NCT01547806

PHASE2INTERVENTIONAL
National Cancer Institute (NCI)
49 participants
Started 2012-02-22 · Completed 2018-01-11
Status: Completed (as of 12-23-2025)

Conditions

Plasma Cell MyelomaMultiple Myeloma

Linked Papers (from SciSciNet-V2)

Total Papers4
Background
1
Result
0
Derived
0
Unknown
3

Total Citations Per Year

Brief Summary

Background: \- One beneficial treatment for plasma cell myeloma is high-dose chemotherapy followed by stem cell transplant. Researchers want to collect stem cells from the blood for later transplant. Objectives: \- To collect stem cells for transplant as part of treatment for plasma cell myeloma. Eligibility: \- Individuals at least 18 years of age who will have chemotherapy and stem cell transplant for plasma cell myeloma. Design: * Participants will be screened with a physical exam and medical history. Blood and urine samples will be collected. * Participants will have filgrastim injections for 5 days before collection. This will move stem cells from the bone marrow to the blood. * Participants will have apheresis to collect the stem cells. * Participants who need additional apheresis procedures to collect stem cells will have filgrastim and a dose of plerixafor to improve the collection yield.